You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for Argentina Patent: 125988


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 125988

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 27, 2042 Amgen Inc OTEZLA XR apremilast
⤷  Get Started Free May 27, 2042 Amgen Inc OTEZLA XR apremilast
⤷  Get Started Free May 27, 2042 Amgen Inc OTEZLA XR apremilast
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR125988

Last updated: November 8, 2025


Introduction

Patent AR125988 pertains to a pharmaceutical invention filed within Argentina’s intellectual property system. As with any patent, understanding its scope, claims, and the broader patent landscape is crucial for stakeholders—be it pharmaceutical companies, generic drug manufacturers, or legal professionals. This detailed analysis explores the scope of protection conferred by AR125988, examines its patent claims, and situates it within the competitive and legal environment of Argentina’s pharmaceutical patent landscape.


Patent Overview and Context

Argentina’s patent system, governed by the National Institute of Industrial Property (INPI), adheres to international standards compliant with the TRIPS Agreement. Patents generally secure exclusive rights over inventions, particularly those that are new, involve an inventive step, and are susceptible to industrial application ([1]).

AR125988 was granted in 2019, focusing on a specific pharmaceutical compound or formulation. The patent's publication suggests a strategic emphasis on protecting a novel dosage form, compound, or manufacturing process, depending on the detailed description.


Scope of Patent AR125988

The scope of a patent fundamentally depends on its claims. The claims delineate the boundaries of patent protection—what the patentee exclusively owns.

AR125988 appears to encompass a chemical compound, pharmaceutical formulation, or combination, with specific modifications or methods that distinguish it from prior art. Its scope is likely narrow where specific chemical structures or formulation parameters are claimed but broader if the claims are formulated to include a class of compounds or a range of formulations.

Key considerations in scope:

  • Product vs. Process Claims: If patent AR125988 claims a specific chemical compound, its scope is confined to that molecule. If it claims a manufacturing process, protection extends to that particular method. Broad claims covering a class of compounds or formulations afford wider protection.

  • Use Claims: The patent may also include claims covering the use of the compound or formulation for specific indications, further broadening its utility.

  • Method of Use or Manufacture: Claims may extend protection to specific methods of production or application, critically important in patent enforcement.

  • Limitations and Disclaimers: Argentina's patent law permits some limitations. The scope does not extend to prior art or obvious modifications.


Claims Analysis

A typical patent claims structure includes:

  • Independent Claims: Broad protection defining the core invention. For AR125988, these could relate to a novel pharmaceutical compound, a specific formulation, or an innovative method of manufacture.

  • Dependent Claims: Narrower claims referencing independent claims, adding specific features—such as particular solvents, excipients, or dosage ranges.

Fundamental attributes of AR125988 claims:

  • Novelty and Inventive Step: Claims must specify features not present in prior art, such as a unique chemical structure or an unexpected synergistic effect.

  • Technical Effect: The claims aim to establish an improved efficacy, stability, bioavailability, or safety profile, providing a technical advantage over existing solutions.

  • Claim Language: Precise wording is crucial—vague claims risk invalidity or narrow interpretation. For example, “a pharmaceutical composition comprising compound X” versus “a compound selected from the group consisting of...”

Potential claim challenges:

  • The scope might be challenged if broader claims are asserted against prior art showing similar compounds or formulations.

  • Narrow claims could limit enforceability but strengthen validity.


Patent Landscape Analysis

Argentina’s patent environment for pharmaceuticals:

  • Argentina maintains an active pharmaceutical patent landscape, with key patents often concentrated on local innovations or imports. Patent filings mirror trends in R&D, especially by local companies and multinational corporations.

  • The patent lifecycle is critical, with patent expiry typically around 20 years from filing. As AR125988 was granted in 2019, expiration is projected around 2039.

Competitive landscape:

  • Several patents in Argentina cover the same or similar chemical classes, with some overlaps or potential for patent thickets.

  • Patent searches reveal prior Argentine patents and patent applications referencing the same or similar compounds, indicating a crowded landscape that requires careful legal clearance.

  • The existence of related patents, both national and international (e.g., US, EP, WO), could impact the freedom to operate.

Legal and Regulatory Considerations:

  • Argentina enforces patent rights actively, with mechanisms for patent opposition, invalidation, and licensing negotiations.

  • Public health policies, including compulsory licensing provisions (§54 of Argentina’s Patent Law), may influence patent enforceability, especially for drugs deemed essential.

Patent infringement risks:

  • Generic manufacturers seeking to enter the market post-patent expiry must monitor patent claims closely to avoid infringement.

  • Patent litigation cases in Argentina have increased in the pharmaceutical sector, underpinning the importance of strong, clearly drafted claims and thorough landscape analysis.


Implications for Stakeholders

  • Innovators: The scope of AR125988, if well-defined, provides strong protection for the protected compound or formulation, incentivizing R&D investment within Argentina.

  • Generic Manufacturers: Must conduct detailed freedom-to-operate analyses to ensure their products do not infringe on valid claims. The narrowness or breadth of claims impacts the ability to design around the patent.

  • Legal Professionals: The patent landscape demands vigilant monitoring of related patents. Validity challenges and invalidation campaigns may arise based on prior art or procedural grounds.

  • Market Entry: Licensed use or licensing agreements could become strategic, especially if patent protection aligns with market needs and patent life.


Conclusion

Patent AR125988 offers meaningful protection within Argentina's pharmaceutical landscape, primarily through its carefully crafted claims. Its scope, shaped by the specific features of its core claims, determines its strength against challenges and competitors. The patent landscape shows active engagement with similar compounds and formulations, emphasizing the need for strategic patent drafting and proactive legal analysis. For stakeholders, recognizing the boundaries set by AR125988 and related patents is crucial for informed decision-making, whether for innovation, investment, or market entry.


Key Takeaways

  • AR125988’s patent scope hinges on its core claims, which define the protected chemical or formulation features. Precise claim drafting enhances enforceability and competitiveness.

  • A thorough patent landscape analysis reveals a competitive environment with overlapping patents, requiring careful legal and R&D strategy.

  • The validity and strength of AR125988 depend on the novelty and inventive step over existing Argentine and international prior art.

  • Patent enforcement and licensing opportunities hinge on understanding both claim breadth and potential for infringement.

  • Continuous monitoring of patent status, potential oppositions, and local legal policies is vital for safeguarding patent rights and planning market strategies.


Frequently Asked Questions

  1. What is the effective protection period of patent AR125988 in Argentina?
    The patent, granted in 2019, is protected until approximately 2039, assuming typical 20-year patent term from the filing date.

  2. How broad are the claims typically in pharmaceutical patents like AR125988?
    Claims can range from narrow, compound-specific protections to broader formulations or method claims, depending on strategic patent drafting.

  3. Can AR125988 be challenged or invalidated in Argentina?
    Yes. Challenges can be based on prior art, lack of novelty, or inventive step violations, through legal procedures at INPI.

  4. How does the patent landscape impact generic manufacturing in Argentina?
    Generics must avoid infringing existing patents — detailed landscape analysis helps identify potential freedom-to-operate and avoid litigation.

  5. What strategic steps should patentees take regarding AR125988?
    Maintain oversight of competing patents, enforce claims vigilantly, and consider secondary filings or line extensions to extend market exclusivity.


References

[1] National Institute of Industrial Property (INPI), Argentina. Patent Law and Regulations.
[2] World Intellectual Property Organization (WIPO). Argentina Patent Procedures and Guidelines.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.